InvestorsHub Logo
Followers 5
Posts 290
Boards Moderated 0
Alias Born 11/07/2014

Re: drugrunner post# 275814

Tuesday, 04/07/2020 4:24:38 PM

Tuesday, April 07, 2020 4:24:38 PM

Post# of 686621
Mesoblast's Remistemcel-L was cleared by the FDA yesterday for expanded access compassionate use in ARDS (acute respiratory distress syndrome) cased by COVID-19. You may want to see if this may be relevant for your friend.

https://finance.yahoo.com/news/fda-clears-investigational-drug-application-100010964.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News